Human herpesvirus 7
(Redirected from Human betaherpesvirus 7)
Human herpesvirus 7 | |
---|---|
Synonyms | HHV-7 |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Fever, rash, seizures |
Complications | Roseola, encephalitis |
Onset | Childhood |
Duration | Lifelong |
Types | N/A |
Causes | Human herpesvirus 7 infection |
Risks | Immunocompromised individuals |
Diagnosis | Serology, PCR |
Differential diagnosis | Human herpesvirus 6, Measles, Rubella |
Prevention | None |
Treatment | Supportive care |
Medication | Antiviral drugs |
Prognosis | N/A |
Frequency | Ubiquitous |
Deaths | Rare |
Human herpesvirus 7 (HHV-7) is a member of the Herpesviridae family, which is a group of viruses known for causing various forms of herpes infections. HHV-7 is closely related to Human herpesvirus 6 (HHV-6), sharing many biological properties and having a similar genetic structure. It is one of the lesser-studied viruses within the herpes family, primarily because it is often overshadowed by its more notorious relatives such as Herpes simplex virus 1 (HSV-1) and Herpes simplex virus 2 (HSV-2).
Discovery
HHV-7 was first isolated in 1990 from activated T lymphocytes, a type of white blood cell that plays a central role in immune response. The discovery of HHV-7 expanded the known spectrum of herpesviruses affecting humans, contributing to a deeper understanding of viral infections and their interactions with the immune system.
Virology
HHV-7 is a DNA virus with a double-stranded DNA genome. Like other herpesviruses, it has the ability to remain latent in the host's body after the initial infection and can reactivate under certain conditions, such as immunosuppression or stress.
Epidemiology
Infection with HHV-7 is common worldwide, with a significant proportion of the population acquiring the virus during childhood. The primary mode of transmission is thought to be through saliva, which explains the high prevalence among young children who are in close contact with each other.
Clinical Manifestations
The majority of HHV-7 infections are subclinical, meaning they do not cause noticeable symptoms. However, in some cases, HHV-7 can lead to conditions such as Exanthem subitum (also known as roseola infantum or sixth disease), a common childhood illness characterized by high fever and a rash. Other potential manifestations include febrile seizures, encephalitis, and complications in immunocompromised individuals.
Diagnosis
Diagnosing HHV-7 involves detecting the viral DNA or antibodies against the virus in clinical specimens. Techniques such as polymerase chain reaction (PCR) are commonly used for this purpose, providing a direct method for identifying HHV-7 DNA in blood, saliva, or other tissues.
Treatment and Prevention
There is no specific treatment for HHV-7 infections, and management typically focuses on symptomatic relief. Antiviral drugs, such as ganciclovir, have been used in severe cases, particularly in immunocompromised patients. Preventive measures are limited due to the ubiquitous nature of the virus and the common routes of transmission.
Research and Future Directions
Research on HHV-7 continues to explore its role in various diseases and its potential interactions with other pathogens. Understanding the full impact of HHV-7 on human health and its interactions with the immune system remains a significant area of ongoing study.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD